According to the Institute of Medicine, over 1.5 million Americans get sick, injured, or killed by errors in dispensing, prescribing, and taking medications every year. A study in the British Medical ...

As the pharmaceutical industry moves toward continuous manufacturing, new documents are needed to provide flexible guidance that meets the new process requirements. Since 2000, there have been ...

In order to continue to be viable in the next decade, the pharmaceutical industry is adapting in ways that might seem surprising just a few years ago. The pressure to reduce costs coupled with the ...

Pharmaceutical Sales Representatives (Reps) are employed by pharmaceutical, biotechnology, or healthcare companies to sell their pharmaceutical products to external stakeholders, e.g., physicians.

The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

Do pharmaceutical companies seek approval outside the USA if the FDA is slow? originally appeared on Quora: the place to gain and share knowledge, empowering people to learn from others and better ...

In today’s ever-changing market place, pharmaceutical companies are challenged to reach, engage and persuade physicians in new, more effective ways. With changing behavioral influences, rising ...

Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing ...

As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life sciences sector has been squarely in the spotlight. In the UK, the Government has often said that ...

In order to end this pandemic, everyone must play their part, and that includes the private sector. Their leadership, innovation, skills, knowledge, and financial muscle are desperately needed. This ...

Look here for a clue. There's no foolproof way to know the future for BioMarin Pharmaceutical (Nasdaq: BMRN) or any other company. However, certain clues may help you see potential stumbles before ...